Sano Chemicals is an early stage biotechnology company primarily focused on the development of novel anti-infectives for clinical and agricultural use. The firm has locations in College Station, TX and Starkville, MS. There is a need to identify new antifungals for the treatment of serious fungal infections. Given an increasing population of immunocompromised individuals, in particular those undergoing treatment for cancer, fungal infections lead to debilitative illnesses and these patients have a high mortality rate. The firm is focused on the antifungal occidiofungin. Current studies support investigational studies aimed at determining occidiofungin's therapeutic potential for the treatment of life threatening fungal infections. These data support studies aimed at investigating the compound's ability to be given orally versus intravenously. If these studies prove to be successful, occidiofungin would be the only orally administered fungicidal drug.
